Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Amortization of premiums and discounts on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Less: Accumulated depreciation Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Additional paid-in capital Additional Paid in Capital Depreciation expense Depreciation Common stock options, RSUs and ESPP shares Common stock options, restricted stock units and ESPP shares Shares available for future stock incentive awards Statement of Financial Position [Abstract] Basic (in dollars per share) Earnings Per Share, Basic Equity Interest Issued or Issuable, Type [Domain] Equity Interest Issued or Issuable, Type [Domain] Percentage acquired Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Schedule of Pro forma Financial Information Business Acquisition, Pro Forma Information [Table Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Acquisitions Business Combinations Policy [Policy Text Block] Cash assumed in acquisition of Old Cartesian Cash Acquired from Acquisition Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Cash payments for employee related restructuring charges Payments Payments Payments for Restructuring Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Accounts receivable Increase (Decrease) in Accounts Receivable Valuation allowance, deferred tax asset, increase (decrease), amount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Income taxes payable Increase (Decrease) in Income Taxes Payable Prepaid expenses, deposits and other assets Increase (Decrease) in Prepaid Expense and Other Assets Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts payable Increase (Decrease) in Accounts Payable Commercial paper Commercial paper Commercial Paper [Member] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Ending balance (in shares) Beginning balance (in shares) Common Stock, Shares, Outstanding Common stock, $0.0001 par value; 350,000,000 shares authorized as of December 31, 2023 and December 31, 2022; 161,927,821 and 153,042,435 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively Common stock, $0.0001 par value; 350,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 17,816,238 and 5,397,597 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively Total comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Computer Equipment Computer equipment and software Computer Equipment [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Concentration Risk [Table] Concentration Risk [Table] Variable Interest Entities Consolidation, Variable Interest Entity, Policy [Policy Text Block] Convertible preferred stock (in shares) Convertible Preferred Stock, Shares Issued upon Conversion Operating expenses: Cost of Revenue [Abstract] Income tax expense (benefit) Current Income Tax Expense (Benefit) Total current liabilities Liabilities, Current Current liabilities: Liabilities, Current [Abstract] Debt Debt Disclosure [Text Block] Final payment fee Debt instrument, fee amount Debt Instrument, Fee Amount Provision (benefit) for deferred taxes Deferred Income Tax Expense (Benefit) Gross deferred tax liabilities Deferred Tax Liabilities, Gross Deferred Tax Assets Deferred Tax Assets, Gross [Abstract] Deferred revenue Deferred Tax Assets, Deferred Income Gross deferred tax assets Deferred Tax Assets, Gross R&E Capitalization Deferred Tax Asset, In-Process Research and Development Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Research and development credits Deferred Tax Assets, Tax Credit Carryforwards, Research Stock-based compensation expense Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Other expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other Valuation allowance Deferred Tax Assets, Valuation Allowance Deferred Tax Liabilities Deferred Tax Liabilities, Gross [Abstract] Intangible assets Deferred Tax Liabilities, Intangible Assets Net deferred tax assets/(liabilities) Deferred Tax Liabilities, Net Operating lease right-of-use assets Deferred Tax Liabilities, Leasing Arrangements Employer contribution made Employer contribution made, net Depreciation and amortization Other Depreciation and Amortization Forward contract liabilities Derivative Liability, Current Forward Contract Liabilities Derivatives, Policy [Policy Text Block] Diluted (in dollars per share) Earnings Per Share, Diluted Principles of Consolidation Consolidation, Policy [Policy Text Block] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Valuation allowance, net Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Statutory U.S. federal rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Permanent items Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Stock-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent State income taxes - net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Research tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent Total stock-based compensation expense Stock based compensation expense Stock-based compensation expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Shares of common stock issued to employees under the ESPP (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Laboratory Equipment, Software and Office Equipment Equipment [Member] Equity Interest Type [Axis] Equity Interest Type [Axis] Principal amount extinguished Extinguishment of debt, amount Extinguishment of Debt, Amount Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Domestic Tax Authority Domestic Tax Jurisdiction [Member] Debt amendment fee included in debt discount Payments of Financing Costs Furniture and fixtures Furniture and Fixtures [Member] Change in fair value of forward contract liabilities Forward contract liabilities revaluation Loss (gain) on disposal of property and equipment Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt General and administrative General and Administrative Expense General and administrative General and Administrative Expense [Member] Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Indefinite-Lived Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block] Impairment to goodwill Goodwill, Impairment Loss Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Penalties and interest Income Tax Examination, Penalties and Interest Expense Income Tax Examination [Line Items] Income Tax Examination [Line Items] Income Tax Examination [Table] Income Tax, Examination [Table] Income Taxes Income Tax Disclosure [Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Dilutive effect of employee equity incentive plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Indefinite-Lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Goodwill Goodwill Goodwill In-process research and development assets Carrying Value Indefinite-Lived Intangible Assets (Excluding Goodwill) Interest expense Interest Expense, Operating and Nonoperating Interest expense related to term loans Interest Expense, Debt Investment income Investment Income, Net Marketable Securities and Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Leasehold improvements Leasehold Improvements [Member] Letter of Credit Letter of Credit [Member] Total liabilities Liabilities Total liabilities, convertible preferred stock, and stockholders' (deficit) equity Liabilities and Equity Liabilities, convertible preferred stock, and stockholders' (deficit) equity Liabilities, convertible preferred stock, and stockholders' deficit Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Line of Credit Facility [Table] Line of Credit Facility [Table] Outstanding borrowings Term loan facility Long-Term Line of Credit Loan payable, net of current portion Loans Payable, Noncurrent Loan payable Loans Payable, Current Money market funds (included in cash equivalents) Money Market Funds [Member] Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Axis] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Net income (loss) Net (loss) income Net income (loss) Net Income (Loss) Net (loss) income allocable to shares of common stock - basic Net loss allocable to shares of common stock - basic Proceeds from issuance of common stock under Employee Stock Purchase Plan Proceeds from Stock Plans Non-current assets: Assets, Noncurrent [Abstract] Office equipment Office Equipment [Member] Operating loss carryforwards Operating Loss Carryforwards Operating (loss) income Operating Income (Loss) Total revenue Revenues Description of the Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Other comprehensive (loss) income: Other comprehensive income (loss): Other Comprehensive Income (Loss), Tax [Abstract] Unrealized gain (loss) on marketable securities Unrealized gain on marketable securities Unrealized gain on marketable securities Other income, net Other Nonoperating Income (Expense) Defined Contribution Plan Retirement Benefits [Text Block] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Net proceeds from issuance of common stock- at-the-market offering Proceeds from Issuance of Common Stock Proceeds from issuance of Series A Preferred Stock, gross in private placement Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from maturities of marketable securities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Proceeds from exercise of stock options Proceeds from Stock Options Exercised Total property and equipment Property, Plant and Equipment, Gross Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Property, Plant and Equipment [Abstract] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Payment made for investments Payments to Acquire Other Investments Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Domain] Consulting services expenses Related Party Transaction, Amounts of Transaction Related Party Transaction [Line Items] Related Party Transaction [Line Items] Related-Party Transactions Related Party Transactions Disclosure [Text Block] Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Table] Repayments of principal, final payment fee, and prepayment penalty on debt Total payoff amount of term loan Total payoff amount of term loan Repayments of Long-Term Debt Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Short-term restricted cash Restricted Cash and Cash Equivalents, Current Restructuring charges Charges Restructuring Charges Restructuring Restructuring and Related Activities Disclosure [Text Block] Beginning Balance Ending Balance Restructuring Reserve Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Sale of Stock [Domain] Sale of Stock [Domain] Sale of stock, number of shares issued in transaction (in shares) Shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Sale of stock, price per share (in dollars per share) Share price (in dollars per share) Sale of Stock, Price Per Share Sale common stock Sale of stock, consideration received on transaction Total aggregate purchase price Schedule of Intangible Assets Acquired Schedule of Acquired Indefinite-Lived Intangible Assets by Major Class [Table Text Block] Schedule of Fair Value of Consideration Schedule of Business Acquisitions, by Acquisition [Table Text Block] Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Marketable securities Debt Securities, Available-for-Sale, Current Series B Preferred Stock Series B Preferred Stock [Member] Series A Preferred Stock Series A Preferred Stock [Member] Forfeited in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Grants in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Grants in period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Unvested at end of period (in shares) Unvested at beginning of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Unvested at beginning of period (in dollars per share) Unvested at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Vested in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested in period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Number of shares authorized for grants (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Cancelled/settled in connection with the Merger (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Weighted average grant date fair value of stock options (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Beginning balance (in shares) Share-based compensation arrangement by share-based payment award, options, outstanding, number (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Ending balance (in dollars per share) Beginning balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Award Type [Domain] All Award Types Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] State and Local Jurisdiction State and Local Jurisdiction [Member] Statement of Cash Flows [Abstract] Statement of Comprehensive Income [Abstract] Statement of Stockholders' Equity [Abstract] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Issuance costs Payments of Stock Issuance Costs Stockholders' (deficit) equity: Stockholders' deficit: Class of warrant or right, outstanding, ending balance (in shares) Class of warrant or right, outstanding, beginning balance (in shares) Class of warrant or right, outstanding (in shares) Class of Warrant or Right, Outstanding Equity Equity [Text Block] Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event [Line Items] Subsequent Event [Line Items] Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Sale of Stock [Axis] Sale of Stock [Axis] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Supplement cash flow information Supplemental cash flow information Supplemental Cash Flow Information [Abstract] Tax credit carryforward, amount Tax Credit Carryforward, Amount Total current assets Assets, Current Current assets: Assets, Current [Abstract] Warrants to purchase common stock Warrant Exercise of warrants Warrant liabilities Warrant liabilities, net of current portion Warrants and Rights Outstanding Diluted (in shares) Weighted-average common shares used in per share calculations - diluted (in shares) Weighted-average common shares outstanding - diluted (in shares) Dilutive effect of employee equity incentive plans and outstanding warrants (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Basic (in shares) Weighted-average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Unamortized debt issuance cost Deferred debt issuance cost, writeoff Deferred Debt Issuance Cost, Writeoff Long-term restricted cash Long-term restricted cash Restricted Cash and Cash Equivalents, Noncurrent Common stock Common Stock [Member] Construction in process Construction in Progress [Member] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Research and development Research and Development Expense Cash maintained in Russian bank accounts Cash Series A Preferred Stock Preferred Stock [Member] Marketable securities Fair value Marketable securities: Total assets Assets Non-current liabilities: Other Liabilities, Noncurrent [Abstract] Income Tax Jurisdiction [Domain] Income Tax Jurisdiction [Domain] Financial Instruments [Domain] Financial Instruments [Domain] Schedule of Restructuring and Related Costs [Table] Restructuring Cost [Table] Stock Incentive Plans Share-Based Payment Arrangement [Text Block] Money market funds (included in cash equivalents) Cash and Cash Equivalents, Fair Value Disclosure Statement [Table] Statement [Table] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Assets Assets [Abstract] Statement [Line Items] Statement [Line Items] Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net Schedule of Changes in the Fair Value of Liabilities Schedule of Changes in the Warrant Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Change in fair value Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Schedule of Stockholders' Equity Note, Warrants or Rights Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Equity [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Temporary equity, shares authorized (in shares) Authorized shares of Preferred Stock (in shares) Temporary Equity, Shares Authorized Temporary equity, shares issued (in shares) Temporary Equity, Shares Issued Temporary equity, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Temporary Equity, Shares Outstanding Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Class of Stock [Domain] Class of Stock [Domain] Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Reclassification of warrant liabilities Adjustments to Additional Paid in Capital, Warrant Issued Total operating expenses Collaboration expense Collaboration expense Operating Expenses Net (loss) income per share: Net income (loss) per share allocable to common stockholders: Total (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities [Axis] Antidilutive Securities [Axis] Potential common shares Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Earnings Per Share [Abstract] Net (loss) income per share: Net income (loss) per share allocable to common stockholders: Schedule of Potential Common Shares Issuable Upon Conversion of Warrants Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Net (Loss) Income Per Share Earnings Per Share, Policy [Policy Text Block] Schedule of Change in Accrued Restructuring Balance Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Class of Stock [Axis] Class of Stock [Axis] Deferred rent Deferred Rent Credit, Current Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Common stock authorized and reserved for future issuance (in shares) Total (in shares) Common Stock, Capital Shares Reserved for Future Issuance Debt Issuance Costs Debt, Policy [Policy Text Block] Total stockholders' (deficit) equity Ending balance Beginning balance Equity, Attributable to Parent Depreciation Deferred Tax Liabilities, Property, Plant and Equipment Income tax benefit (expense) Income Tax Expense (Benefit) Foreign currency transaction gain (loss), net Foreign currency transaction, net Gain (Loss), Foreign Currency Transaction, before Tax Preferred stock, $0.0001 par value; 9,451,625 and 10,000,000 shares authorized as of December 31, 2023 and December 31, 2022, respectively; no shares issued and outstanding as of December 31, 2023 and December 31, 2022 Preferred stock, value, issued U.S. government agency securities and treasuries U.S. government agency securities and treasuries US Government Agencies Debt Securities [Member] Equity Components [Axis] Equity Components [Axis] Additional paid-in capital Additional Paid-in Capital [Member] Accumulated deficit Retained Earnings [Member] Accumulated other comprehensive loss AOCI Attributable to Parent [Member] Equity Component [Domain] Equity Component [Domain] Purchase of property and equipment not yet paid Capital Expenditures Incurred but Not yet Paid Outstanding Series A Preferred Stock options Options Options Outstanding common stock options Non-cash interest expense Paid-in-Kind Interest Issuance of common stock under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common stock in connection with the Merger and settlement of related forward contract Stock Issued During Period, Value, Acquisitions Issuance of common stock upon exercise of options Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock upon exercise of warrants and Conversion of Series A Preferred Stock to common stock Stock Issued During Period, Value, Conversion of Convertible Securities Issuance of common stock, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues Issuance of common stock under Employee Stock Purchase Plan (in shares) Issuance of common stock under Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of vested restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Issuance of common stock in connection with the Merger and settlement of related forward contract (in shares) Stock Issued During Period, Shares, Acquisitions Issuance of common stock upon exercise of options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Issuance of common stock upon exercise of warrants and Conversion of Series A Preferred Stock to common stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Contingent Liabilities Commitments and Contingencies, Policy [Policy Text Block] Net (loss) income allocable to shares of common stock - diluted Net loss allocable to shares of common stock - diluted Less: Change in fair value of warrants Dilutive Securities, Effect on Basic Earnings Per Share Equity offering costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Dividends declared or paid on common stock Dividends, Common Stock Property and equipment, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Revenues Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Net loss Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Net Income (Loss) Per Share Allocable to Common Stockholders Net (Loss) Income Per Share Transaction costs Business Combination, Acquisition Related Costs Weighted-average common shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Spark License Agreement License Agreement Terms [Member] Billing Status, Type [Axis] Billing Status, Type [Axis] Receivables Billing Status [Domain] Receivables Billing Status [Domain] Billed Revenues Billed Revenues [Member] Merger Business Combination Disclosure [Text Block] Class of Stock [Line Items] Class of Stock [Line Items] Schedule of Authorized Shares of Common Stock for Future Issuance Schedule of Stock by Class [Table Text Block] Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Leases [Abstract] Commitments and contingencies (Note 19) Commitments and contingencies (Note 18) Restricted cash and cash equivalents Restricted Cash and Cash Equivalents Adjustments to reconcile net (loss) income to net cash used in operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Accounts payable Accounts Payable, Current Accrued expenses Accrued Liabilities, Current Payroll and employee related expenses Employee-related Liabilities, Current Other Other Accrued Liabilities, Current Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Impairment of intangible assets Impairment Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) (Loss) income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Less: CVR distribution to participating securities Distributed Earnings Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Preferred stock Temporary Equity [Line Items] Temporary equity, par value (in dollars per share) Temporary equity, par value (in dollars per share) Temporary Equity, Par or Stated Value Per Share Total assets Assets, Fair Value Disclosure Total liabilities Liabilities, Fair Value Disclosure Issuance of Series A Preferred Stock forward in connection with private placement and settlement of related forward contract Issuance of Series A Preferred Stock in connection with private placement and settlement of related forward contract Temporary Equity, Stock Issued During Period, Value, New Issues Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Measurement Frequency [Domain] Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Other assets Other Assets Recurring Fair Value, Recurring [Member] Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Proceeds from exercise of common warrants Proceeds from Warrant Exercises Redemption premium Redemption Premium Issuances Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Payables and Accruals [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Investments, Debt and Equity Securities [Abstract] Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Fair value Fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Schedule of Authorized Shares of Preferred Stock for Future Issuance Temporary Equity [Table Text Block] Liability Class [Axis] Liability Class [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Axis] Measurement Frequency [Axis] Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Assets Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Schedule of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Issuance of common stock through at-the-market offering, net Stock Issued During Period, Value, Other Issuance of common stock through at-the-market offering, net (in shares) Stock Issued During Period, Shares, Other Income Tax Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Fair Value Disclosures [Abstract] Subsequent Events Subsequent Events [Text Block] Debt Disclosure [Abstract] Amortized cost Debt Securities, Available-for-Sale, Amortized Cost Retirement Benefits [Abstract] Schedule of Stock-Based Compensation Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of Options Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Weighted Average Assumptions Used Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Letters of credit outstanding, amount Letter of credit outstanding Letters of Credit Outstanding, Amount Share-Based Payment Arrangement [Abstract] Restructuring and Related Activities [Abstract] Use of Estimates Use of Estimates, Policy [Policy Text Block] Segment Information Segment Reporting, Policy [Policy Text Block] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Assets: Assets, Fair Value Disclosure [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Schedule of Significant Inputs Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Liabilities: Liabilities, Fair Value Disclosure [Abstract] Research and development Research and Development Expense [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Accounting Policies [Abstract] Temporary Equity Disclosure [Abstract] Related Party Transactions [Abstract] Subsequent Events [Abstract] Employee workforce, termination percentage Number of positions eliminated, period percent Issuance of shares (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Revenue Business Acquisition, Pro Forma Revenue Net (loss) income Business Acquisition, Pro Forma Net Income (Loss) Collaborative Arrangement Collaborative Arrangement [Member] Issuance of common stock, license agreement in stock-based compensation expense Stock Issued Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Income Tax Jurisdiction [Axis] Income Tax Jurisdiction [Axis] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Non-cash investing and financing activities Noncash investing and financing activities Noncash Investing and Financing Items [Abstract] Schedule of Computation of Basic and Diluted Net (Loss) Income Per Share Schedule of Computation of Basic and Diluted Net (Loss) Income Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Forfeited in period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Unrecognized compensation expense related to unvested employee stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Accumulated Other Comprehensive Income (Loss) Comprehensive Income, Policy [Policy Text Block] Financial Instrument [Axis] Financial Instrument [Axis] Series A Preferred Stock, $0.0001 par value; 548,375 and no shares authorized as of December 31, 2023 and December 31, 2022, respectively; 435,120.513 and no shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively Beginning balance Ending balance Series A Preferred Stock, $0.0001 par value; no and 548,375 shares authorized as of June 30, 2024 and December 31, 2023, respectively; no and 435,120.513 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively Temporary Equity, Carrying Amount, Attributable to Parent Weighted-average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Cancelled/settled in connection with the Merger (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Award Type [Axis] Award Type [Axis] Schedule of Cash and Cash Equivalents [Table] Cash and Cash Equivalent [Table] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Subsequent Event Subsequent Event [Member] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Share-based payment arrangement, accelerated cost Share-Based Payment Arrangement, Accelerated Cost Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Concentrations of Credit Risk and Off-Balance Sheet Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Accrued expenses and other current liabilities Accrued Liabilities and Other Liabilities Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Patent and license costs Deferred Tax Assets, Goodwill and Intangible Assets Estimated useful life Property, Plant and Equipment, Useful Life Schedule of Related Party Transactions Schedule of Related Party Transactions [Table Text Block] Outstanding, term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Vested and expected to vest, term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Expected term (in years) Expected term Award vesting term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Weighted average period Weighted average period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Number of operating segments Number of Operating Segments Area of office space leased Area of office space leased Area of Real Estate Property Change in fair value Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Fair value as of December 31, 2023 Fair value Fair value as of June 30, 2024 Issuances Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues Settlements Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements Reverse stock split conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Foreign currency translation adjustment Currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Corporate bonds Corporate bonds Corporate Bond Securities [Member] Class of warrant or right, number of securities called by each warrant or right (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Change in fair value of warrant liabilities Warrant liabilities revaluation Fair Value Adjustment of Warrants Award expiration term Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Total consideration Business Combination, Consideration Transferred Assets acquired: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract] Liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract] Forward contract to issue stock and options Forward contract to issue stock Business Combination, Consideration Transferred, Liabilities Incurred Settlement of forward contract liability Settlement of forward contract liability Business Combination, Consideration Transferred, Equity Interests Issued and Issuable In-process research and development assets Acquisition Date Fair Value Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Less: Undistributed earnings allocable to participating securities, basic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Less: Undistributed earnings allocable to participating securities, diluted Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted Weighted average exercise price (in dollars per share) Exercise price, beginning balance (in dollars per share) Exercise price, ending balance (in dollars per share) Exercise price (in dollars per share) Deferred tax liabilities, net Deferred Income Tax Liabilities, Net Deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Less sublease income Less: Sublease income Lessee-paid construction costs Total lease cost Lease, Cost Operating lease cost Operating Lease, Cost Short-term lease cost Short-Term Lease, Cost Variable lease cost Variable Lease, Cost Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Contract with customer, asset, reclassified to receivable Contract with Customer, Asset, Reclassified to Receivable Revenue recognized Deductions Contract with Customer, Liability, Revenue Recognized Unbilled receivables Unbilled receivables Contract with Customer, Asset, after Allowance for Credit Loss, Current Revenue from Contract with Customer [Abstract] Revenue Arrangements Revenue from Contract with Customer [Text Block] Deferred revenue Short-term contract liability Contract with Customer, Liability, Current Deferred revenue, net of current portion Long-term contract liability Contract with Customer, Liability, Noncurrent Contract liabilities, ending balance Contract liabilities, beginning balance Deferred revenue related to agreement Contract with Customer, Liability Right-of-use asset, net Operating Lease, Right-of-Use Asset Collaboration and license revenue Revenue from Contract with Customer, Excluding Assessed Tax Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Restricted cash, current Restricted Cash, Current Restricted cash, noncurrent Long-term restricted cash Restricted Cash, Noncurrent Restricted cash Restricted cash Restricted Cash Effect of exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Net change in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash paid for amounts included in the measurement of lease liabilities: Operating Lease, Payments Weighted-average discount rate Operating lease, weighted average discount rate, percent Weighted-average discount rate Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five 2024 2025 Lessee, Operating Lease, Liability, to be Paid, Year One 2028 Lessee, Operating Lease, Liability, to be Paid, Year Five 2027 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four 2026 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three 2025 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two 2024 (remainder) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Schedule of Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of Operating Lease, Lease Income Operating Lease, Lease Income [Table Text Block] Non-cash lease expense Finance Lease, Right-of-Use Asset, Amortization Right-of-use asset impairment expense Impairment of Right of use asset Operating Lease, Impairment Loss Lease liabilities Total operating lease liabilities Operating Lease, Liability Lease liability Operating Lease, Liability, Current Less: Imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Lease liability, net of current portion Operating Lease, Liability, Noncurrent Schedule of Changes in Contract Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Revenue, remaining performance obligation recognized Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price Schedule of Lease, Cost Lease, Cost [Table Text Block] Leases Lessee, Leases [Policy Text Block] Leases Lessee, Operating Leases [Text Block] Measurement Input Type [Axis] Measurement Input Type [Axis] Risk-adjusted discount rate Measurement Input, Discount Rate [Member] Dividend yield Measurement Input, Expected Dividend Rate [Member] Expected life (in years) Measurement Input, Expected Term [Member] Expected volatility Measurement Input, Price Volatility [Member] Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Measurement Input Type [Domain] Measurement Input Type [Domain] Valuation Technique, Option Pricing Model Valuation technique, option pricing model Valuation technique, option pricing model Warrants and rights outstanding, measurement input Warrants and Rights Outstanding, Measurement Input Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Lease term Lessee, Operating Lease, Term of Contract Lease renewal term Lease renewal term (in years) Lessee, Operating Lease, Renewal Term Schedule of Available-for-Sale Marketable Securities Debt Securities, Available-for-Sale [Table Text Block] Investments Equity securities without readily determinable fair value, amount Equity Securities without Readily Determinable Fair Value, Amount Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Warrants and rights outstanding, term Warrants and Rights Outstanding, Term Grantee Status [Axis] Grantee Status [Axis] Grantee Status [Domain] Grantee Status [Domain] Employees Share-Based Payment Arrangement, Employee [Member] Non-employee consultants Share-Based Payment Arrangement, Nonemployee [Member] Grant revenue Revenue Not from Contract with Customer Fair Value, Net Derivative Asset (Liability), Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Change in fair value, location Fair Value, Net Derivative Asset (Liability), Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Preferred stock, convertible, conversion ratio Rounding down per-share exercise price (in shares) Convertible preferred stock, common stock issuable upon conversion (in shares) Preferred Stock, Convertible, Shares Issuable Business Combination and Asset Acquisition [Abstract] Warrant, increase (decrease) in equity, amount Warrant, Down Round Feature, Increase (Decrease) in Equity, Amount Grand Revenue Government Assistance [Policy Text Block] Government Assistance, Type [Domain] Government Assistance, Type [Domain] Government assistance, asset, current Government Assistance, Asset, Current Government Assistance, Type [Axis] Government Assistance, Type [Axis] Related Party Related Party [Member] Government assistance, award amount Government Assistance, Award Amount Interest expense Interest Expense, Nonoperating Title of Individual [Domain] Title and Position [Domain] Previously Reported [Member] Geographical [Domain] Geographical [Domain] Geographical [Axis] Geographical [Axis] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Maximum Maximum [Member] Minimum Minimum [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Title of Individual [Axis] Title and Position [Axis] Ownership [Axis] Ownership [Axis] Ownership [Domain] Ownership [Domain] Revision of Prior Period [Axis] Revision of Prior Period [Domain] Russian Subsidiary Russian Subsidiary RUSSIAN FEDERATION Cover [Abstract] Document Type Amendment Flag Entity Registrant Name Entity Central Index Key Entity Filer Category Entity Small Business Entity Emerging Growth Company Common Stock, Shares, Outstanding, Proforma As If Preferred Stock Converted Common Stock, Shares, Outstanding, Proforma As If Preferred Stock Converted Common stock, shares, outstanding, proforma as if preferred stock converted (in shares) Directors And Executive Officers Directors And Executive Officers [Member] Directors and Executive Officers Convertible Preferred Stock, Conversion Restriction, Beneficial Ownership Convertible Preferred Stock, Conversion Restriction, Beneficial Ownership Convertible preferred stock, conversion restriction, beneficial ownership Contract With Customer, Milestone Payments Received Contract With Customer, Milestone Payments Received Milestone payments Government Assistance, Potential Additional Award Amount Government Assistance, Potential Additional Award Amount Government assistance, potential additional award amount National Institute Of Neurological Disorders And Stroke Of The National Institutes Of Health Funding National Institute Of Neurological Disorders And Stroke Of The National Institutes Of Health Funding [Member] National Institute of Neurological Disorders and Stroke of the National Institutes of Health Funding Restricted Stock Units, Unvested Restricted Stock Units, Unvested [Member] Unvested restricted stock units Number of warrants exercised during the current period. Stock Issued During Period Shares Warrants Exercised Exercises (in shares) Exercise of warrants (in shares) Class Of Warrant Or Right, Exercise Price Of Warrants Or Rights, Exercises Class Of Warrant Or Right, Exercise Price Of Warrants Or Rights, Exercises Exercises (in dollars per share) Beneficial Ownership Limitation Percentage For Conversion Of Common Stock Issued And Outstanding Beneficial Ownership Limitation Percentage For Conversion Of Common Stock Issued And Outstanding Beneficial ownership limitation percentage for conversion of common stock issued and outstanding Convertible Preferred Stock, Shares That Did Not Automatically Convert Convertible Preferred Stock, Shares That Did Not Automatically Convert Convertible preferred stock, shares that did not automatically convert (in shares) Number Of Business Days Number Of Business Days Number of business days Class of Warrant or Right, Exercised During Period Class of Warrant or Right, Exercised During Period Warrants exercised (in shares) Issuance of Contingent Value Right for Exercise of Warrants Issuance of Contingent Value Right for Exercise of Warrants Issuance of CVRs upon exercise of warrants (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Converted From Options For Preferred Stock Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Converted From Options For Preferred Stock Converted from options for series A Preferred Stock (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Converted From Options For Preferred Stock, Weighted Average Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Converted From Options For Series A Preferred Stock Converted from options for series A Preferred Stock (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Converted To Options For Common Stock Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Converted To Options For Common Stock Converted to options for common stock (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Converted To Options For Common Stock, Weighted Average Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Converted To Options For Common Stock Converted to options for common stock (in dollars per share) 2016 Plan, 2018 Inducement Incentive Award Plan and Old Cartesian Plan 2016 Plan, 2018 Inducement Incentive Award Plan and Old Cartesian Plan [Member] 2016 Plan, 2018 Inducement Incentive Award Plan and Old Cartesian Plan Represents the information pertaining to research and development expenses included in the income statement. Research And Development [Member] Research and development Measurement Input, Revenue Volatility Measurement Input, Revenue Volatility [Member] Expected volatility of future revenues Amount of expenses incurred but not yet paid classified as other excluding property and equipment, due within one year or the normal operating cycle, if longer. Other Accrued Liabilities, Excluding Property and Equipment, Current Other Accrued Property, Plant And Equipment, Current Accrued Property, Plant And Equipment, Current Accrued, Property And equipment Issuance of Stock for Settlement of Forward Contract Liability Issuance of Stock for Settlement of Forward Contract Liability Issuance of stock for settlement of liability Sale of Stock, Gross Consideration Received on Transaction Sale of Stock, Gross Consideration Received on Transaction Sale of stock, gross consideration received on transaction July 2024 Purchase Agreement July 2024 Purchase Agreement [Member] July 2024 Purchase Agreement 2008 Plan, 2016 Plan, and 2018 Inducement Incentive Award Plan 2008 Plan, 2016 Plan, and 2018 Inducement Incentive Award Plan [Member] 2008 Plan, 2016 Plan, and 2018 Inducement Incentive Award Plan Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term Vested, term Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Assumed in Period, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Assumed in Period, Weighted Average Exercise Price Assumed in connection with Merger (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Assumed in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Assumed in Period Assumed in connection with Merger (in shares) n/a Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract] Weighted-average remaining contractual term Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Intrinsic Value Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Intrinsic Value Vested n/a Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value [Abstract] Aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price Vested (in dollars per share) Debt Instrument, Prepayment Fee Debt Instrument, Prepayment Fee Prepayment fee Debt instrument, prepayment fee 2020 Term Loans 2020 Term Loans [Member] 2020 Term Loans Debt Instrument, Accrued Interest Debt Instrument, Accrued Interest Accrued interest Debt instrument, accrued interest Stock Issued During, Warranted Issued, Price Per Share Stock Issued During, Warranted Issued, Price Per Share Issuance (in dollars per share) Stock Issued During, Warrant Reclassification to Equity, Price Per Share Stock Issued During, Warrant Reclassification to Equity, Price Per Share Reclassification of warrant liability to equity on modification (in dollars per share) Stock Issued During, Warranted Canceled, Price Per Share Stock Issued During, Warranted Canceled, Price Per Share Canceled (in dollars per share) Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward] Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward] Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward] Stock Issued During Period Shares Warranted Issued Stock Issued During Period Shares Warranted Issued Issuances (in shares) Stock Issued During Period Shares Warrants Canceled Stock Issued During Period Shares Warrants Canceled Canceled (in shares) Stock Issued During Period Shares Warrant Reclassification to Equity Stock Issued During Period Shares Warrant Reclassification to Equity Reclassification of warrant liability to equity on modification (in shares) Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right [Roll Forward] Represent information pertaining to the 2016 Employee Stock Purchase Plan. Employee Stock Purchase Plan 2016 [Member] ESPP Carrying value as of the balance sheet date of research and development costs. Accrued Research And Development Costs Current Accrued external research and development costs Carrying value as of the balance sheet date of patent fees. Accrued Patent Fees Current Accrued patent fees Accrued Interest, Current Accrued Interest, Current Accrued interest Accrued Audit Fees, Current Accrued Audit Fees, Current Accrued professional and consulting services Pre-Funded Warrant [Member] Pre-Funded Warrant [Member] Pre-Funded Warrant Common Warrant [Member] Common Warrant [Member] Common Warrant December Two Thousand Nineteen Financing [Member] December Two Thousand Nineteen Financing [Member] December 2019 Financing Underwriting Agreement - 2022 Warrants Underwriting Agreement - 2022 Warrants [Member] Underwriting Agreement - 2022 Warrants Springer Purchase Agreement [Member] Springer Purchase Agreement [Member] Springer Purchase Agreement 2017 PIPE [Member] 2017 PIPE [Member] 2017 PIPE Underwriting Agreement Underwriting Agreement [Member] Underwriting Agreement Votes Per Share of Common Stock Votes Per Share of Common Stock Number of votes per share that common stockholders are entitled to Proceed From Issuance Of Common Stock, Net Proceed From Issuance Of Common Stock, Net Net proceeds from issuance of common stock Warrant Issued Warrant Issued Warrant issued Sale of Stock, Percentage Of Ten-Day Volume Weighted Average Price Of Common Stock Sale of Stock, Percentage Of Ten-Day Volume Weighted Average Price Of Common Stock Sale of stock, percentage of ten-day volume weighted average price of common stock Class of Warrant or Right, Number Of Warrants Exercised Class Of Warrant Or Right, Number Of Warrants Exercised Class of warrant or right, number of warrants exercised (in shares) Weighed-average fair value relating to the share-based payment award. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Fair Value Weighted-average fair value of common stock (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease) Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease) Number of shares authorized, increase (in shares) Old Cartestian Old Cartestian [Member] Old Cartestian Represents the percentage of forfeitures rate of the stock options based on the historical trends. Share-based Compensation Arrangement By Share-based Payment Award Forfeitures Rate Estimated forfeitures rate Share Based Compensation Arrangement By Share Based Payment Award, Settlement Of Awards Share Based Compensation Arrangement By Share Based Payment Award, Settlement Of Awards Total cash payment made to the holders of stock options and restricted stock units Share Based Compensation Arrangement By Share Based Payment Award, Settlement Of Awards, Stock Based Compensation Expense Recognized On Settlement Share Based Compensation Arrangement By Share Based Payment Award, Settlement Of Awards, Stock Based Compensation Expense Recognized On Settlement Fair value was recognized as additional stock-based compensation expense in an amount Share Based Compensation Arrangement By Share Based Payment Award, Settlement Of Awards, Amount Share Based Compensation Arrangement By Share Based Payment Award, Settlement Of Awards, Amount Share based compensation arrangement by share based payment award, settlement of awards, amount (in dollars per share) Old Cartesian Plan Old Cartesian Plan [Member] Old Cartesian Plan Employment Inducement Incentive Award Plan [Member] Employment Inducement Incentive Award Plan [Member] Employment Inducement Incentive Award Plan Represents the information pertaining to the 2016 stock incentive plan, which provides for the granting of stock based awards to employees, directors, and consultants under terms and provisions established by the board of directors. Stock Incentive Plan 2016 [Member] 2016 Plan Ginkgo Bioworks Holdings, Inc Ginkgo Bioworks Holdings, Inc [Member] Ginkgo Bioworks Holdings, Inc Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Cancelled Or Settled, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Cancelled Or Settled, Weighted Average Grant Date Fair Value Cancelled/settled in connection with the Merger (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Cancelled Or Settled in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Cancelled Or Settled in Period Cancelled/settled in connection with the Merger (in shares) Lessee, Operating Lease, Liability, To Be Paid, After Year Four Lessee, Operating Lease, Liability, To Be Paid, After Year Four Thereafter Lessee, Operating Lease, Additional Annual Base Rent, Year One Lessee, Operating Lease, Additional Annual Base Rent, Year One Additional annual base rent for first year Operating Lease, Cost Percentage Operating Lease, Cost Percentage Operating lease, cost (as a percent) 7495 New Horizon Way Lease 7495 New Horizon Way Lease [Member] 7495 new Horizon Way Lease Lessee, Operating Lease, First Month Rent Paid on Execution of Lease Agreement Lessee, Operating Lease, First Month Rent Paid on Execution of Lease Agreement Lease agreement, first month's rent paid upon execution of lease agreement Operating Lease, Tenant Improvement Allowance Recognized as Reduction in Right of Use Asset and Lease Liability Operating Lease, Tenant Improvement Allowance Recognized as Reduction in Right of Use Asset and Lease Liability Tenant improvement recognized as reduction in right-of-use asset and lease liability Lessee, Operating Lease, Base Rent, Annual Upward Adjustment Percentage After Year One Lessee, Operating Lease, Base Rent, Annual Upward Adjustment Percentage After Year One Base rent upward annual adjustment percentage after first year 2022 Offering 2022 Offering [Member] 2022 Offering TAS Partners, LLC [Member] TAS Partners, LLC [Member] TAS Partners LLC (affiliate of Timothy A. Springer, Ph.D.) Dr. Timothy A. Springer Dr. Timothy A. Springer [Member] Dr. Timothy A. Springer Timothy A. Springer, Ph.D. Seven One Eight Three Four Irrevocable Trust Seven One Eight Three Four Irrevocable Trust [Member] Seven One Eight Three Four Irrevocable Trust (affiliate of Murat Kalayoglu, MD, Ph.D.) Probability Of Success Probability Of Success [Member] Estimated probability of success Contingent Value Right Liability, Measurement Input Contingent Value Right Liability, Measurement Input Contingent value right liability, measurement input 2019 Warrants 2019 Warrants [Member] 2019 Warrants Preferred Stock, Convertible, Redemption Terms, Period From Merger Preferred Stock, Convertible, Redemption Terms, Period From Merger Preferred stock, convertible, redemption terms, period from merger Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale Cash, cash equivalents, restricted cash and marketable securities Contingent Value Right Liability Contingent Value Right Liability Contingent value right liability 2022 Warrants 2022 Warrants [Member] 2022 Warrants Contingent Value Right Liability, Deduction From Distribution, General And Administrative Overhead Contingent Value Right Liability, Deduction From Distribution, General And Administrative Overhead Fixed semi annual amount Contingent Value Right Contingent Value Right [Member] CVR liability Contingent Value Right Contingent Value Right, Percentage Of Milestone Payments, Royalties And Other Amounts To Be Distributed Contingent Value Right, Percentage Of Milestone Payments, Royalties And Other Amounts To Be Distributed Contingent value right, percentage of milestone payments, royalties and other amounts to be distributed Cash Equivalents And Short Term Investments Cash Equivalents And Short Term Investments [Policy Text Block] Cash Equivalents, Restricted Cash, Marketable Securities and Investments Contingent Value Right Liability, Policy Contingent Value Right Liability, Policy [Policy Text Block] Contingent Value Right Liability Clinical Trial Costs Clinical Trial Costs [Policy Text Block] Clinical Trial Costs Warrants Warrants [Policy Text Block] Warrants Temporary Equity, Policy Temporary Equity, Policy [Policy Text Block] Series A Preferred Stock and Options Genovis AB Genovis AB [Member] Genovis AB Frederick Lease Agreement Frederick Lease Agreement [Member] Frederick lease agreement Lessee, Operating Lease, Monthly Base Rent Lessee, Operating Lease, Monthly Base Rent Lease agreement, monthly base rent Lessee, Operating Lease, Number Of Options To Extend Lessee, Operating Lease, Number Of Options To Extend Number of options to extend lease Stock Based Compensation Expense Incurred But Not Yet Paid Stock Based Compensation Expense Incurred But Not Yet Paid Stock-based compensation expense in accrued liabilities Equity Offering Costs Incurred but not yet Paid Equity Offering Costs Incurred but not yet Paid Equity offering costs in accrued liabilities Transfer Of Temporary Equity To Permanent Equity, Shares Transfer Of Temporary Equity To Permanent Equity, Shares Transfer of Series A Preferred Stock and options for series A Preferred Stock to permanent equity (in shares) Temporary Equity, Options, Transfer Of Preferred Stock To Permanent Equity Temporary Equity, Options, Transfer Of Preferred Stock To Permanent Equity Transfer of Series A Preferred Stock and options for Series A Preferred Stock to permanent equity Temporary Equity, Transfer Of Preferred Stock To Permanent Equity, Shares Temporary Equity, Transfer Of Preferred Stock To Permanent Equity, Shares Transfer of Series A Preferred Stock and options for series A Preferred Stock to permanent equity (in shares) Transfer Of Temporary Equity To Permanent Equity Transfer Of Temporary Equity To Permanent Equity Transfer of Series A Preferred Stock and options for Series A Preferred Stock to permanent equity Temporary Equity, Transfer Of Preferred Stock To Permanent Equity Temporary Equity, Transfer Of Preferred Stock To Permanent Equity Transfer of Series A Preferred Stock and options for Series A Preferred Stock to permanent equity Contract with Customer, Liability, Increase From Cash Receipts Contract with Customer, Liability, Increase From Cash Receipts Additions Contract with Customer, Liability, Deferred Revenue, Increase From Cash Receipts Contract with Customer, Liability, Deferred Revenue, Increase From Cash Receipts Deferred revenue, additions Contract with Customer, Liability, Revenue Recognized, Including Opening Balance Contract with Customer, Liability, Revenue Recognized, Including Opening Balance Deductions Revenue recognized Contract with Customer, Liability, Deferred Revenue, Revenue Recognized Contract with Customer, Liability, Deferred Revenue, Revenue Recognized Deferred revenue, deductions Deferred revenue, deductions Contract with Customer, Liability, Deferred Revenue Contract with Customer, Liability, Deferred Revenue Deferred revenue, end of period Deferred revenue, beginning of period Change In Contract With Customer, Liability [Roll Forward] Change In Contract With Customer, Liability [Roll Forward] Contract liabilities: License And Option Agreement, Future Additional Payments, Expected License And Option Agreement, Future Additional Payments, Expected Future additional payments, expected License And Option Agreement, Upfront Cash Payment License And Option Agreement, Upfront Cash Payment Upfront cash payment Astellas Gene Therapies Astellas Gene Therapies [Member] Astellas Gene Therapies Sarepta Therapeutics, Inc. [Member] Sarepta Therapeutics, Inc. [Member] Sarepta Therapeutics, Inc. License And Option Agreement, Milestone Receivable For Certain Dystrophies License And Option Agreement, Milestone Receivable For Certain Dystrophies Milestone receivable for certain dystrophies AskBio License Agreement AskBio License Agreement [Member] AskBio License Agreement License And Option Agreement, Written Notice Period Before Cancellation License And Option Agreement, Written Notice Period Before Cancellation License and option agreement, written notice period before cancellation Eligible Period To Receive Royalties Eligible Period To Receive Royalties Period after first commercial sale when the Company is eligible to receive royalties Collaboration and License Agreements upfront payment Collaboration and License Agreements upfront payment Collaboration and license agreements upfront payment Upfront payment Takeda Agreement Takeda Agreement [Member] Takeda Agreement Development and Commercial Milestones Plus Royalties Development and Commercial Milestones Plus Royalties Development and commercial milestones plus royalties Collaborative Arrangement, Payment Obligation Collaborative Arrangement, Payment Obligation Collaborative arrangement, payment obligation License And Option Agreement, Sales Milestone Payments That May Be Received License And Option Agreement, Sales Milestone Payments That May Be Received Sales milestone payments License And Option Agreement, Milestone Receivable License And Option Agreement, Milestone Receivable Milestone receivable SOBI Purchase Agreement [Member] SOBI Purchase Agreement [Member] SOBI Purchase Agreement Reimbursement Percentage, Budgeted Costs Incurred To Complete The Development Reimbursement Percentage, Budgeted Costs Incurred To Complete The Development Reimbursement percentage, budgeted costs incurred to complete the development License And Option Agreement, Option Term License And Option Agreement, Option Term Option term License And Option Agreement, Extension Term License And Option Agreement, Extension Term Extension term License And Option Agreement, Development Cost Reimbursements License And Option Agreement, Development Cost Reimbursements License and option agreement, development cost reimbursements Customer, Liability, Revenue Recognized, Including Opening Balance Customer, Liability, Revenue Recognized, Including Opening Balance Customer, liability, revenue recognized, including opening balance License And Option Agreement, Development Milestone License And Option Agreement, Development Milestone Development milestone Revenue, Number Of Performance Obligations Revenue, Number Of Performance Obligations Number of obligations Represents information pertaining to License agreement with Shenyang Sunshine Pharmaceutical co., ltd. License Agreement With Shenyang Sunshine Pharmaceutical Company Limited [Member] 3SBio License Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform Aggregate amount for future payments upon achievement of clinical and regulatory approval milestones for products containing ImmTOR platform Aggregate Amount Of Upfront And Milestone Based Payments Paid Aggregate Amount Of Upfront And Milestone Based Payments Paid Aggregate amount of upfront and milestone-based payments Period which an employee's right to exercise a plan is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Defined Contribution Plan Employers Matching Contribution Vesting Period Vesting period National Cancer Institute Agreement National Cancer Institute Agreement [Member] NCI Agreement License And Option Agreement, Benchmark Royalties, Maximum License And Option Agreement, Benchmark Royalties, Maximum License and option agreement, benchmark royalties, maximum License And Option Agreement, Royalty Payment License And Option Agreement, Royalty Payment License and option agreement, royalty payment Deferred Tax Assets, Leasing Arrangements Deferred Tax Assets, Leasing Arrangements Operating lease liabilities Deferred Tax Assets, Net Of Deferred Tax Liabilities Deferred Tax Assets, Net Of Deferred Tax Liabilities Net deferred tax assets before valuation allowance Capitalized Research And Experimental Costs, Tax Purposes Capitalized Research And Experimental Costs, Tax Purposes Capitalized research and experimental costs, tax purposes License And Option Agreement, Clinical And Commercial Milestone Payment, Expected License And Option Agreement, Clinical And Commercial Milestone Payment, Expected Clinical and commercial milestone payment, expected Collaborative Arrangement, Shares Issued For Milestone Achievement, Amount Collaborative Arrangement, Shares Issued For Milestone Achievement, Amount Collaborative arrangement, shares issued for milestone achievement, amount Ginkgo Agreement Ginkgo Agreement [Member] Ginkgo Agreement Collaborative Arrangement, Number Of Shares Issued For Milestone Achievement Collaborative Arrangement, Number Of Shares Issued For Milestone Achievement Collaborative arrangement, number of shares issued for milestone achievement (in shares) Effective Income Tax Rate Reconciliation, Change In Fair Value Of Contract Liabilities, Percent Effective Income Tax Rate Reconciliation, Change In Fair Value Of Contract Liabilities, Percent Change in fair value of forward contract liabilities Effective Income Tax Rate Reconciliation, Deferred Revenue, Percent Effective Income Tax Rate Reconciliation, Deferred Revenue, Percent Deferred revenue Represents information pertaining to laboratory equipment. Laboratory Equipment [Member] Laboratory equipment Collaborative Arrangement, Cost Share Percentage Collaborative Arrangement, Cost Share Percentage Cost share percentage AskBio License [Member] AskBio License [Member] AskBio License Series B Preferred Stock Purchase Agreement Series B Preferred Stock Purchase Agreement [Member] Series B Preferred Stock Purchase Agreement Equity Securities, Stock Purchase Agreement, Purchase Price Per Share Equity Securities, Stock Purchase Agreement, Purchase Price Per Share Equity securities, stock purchase agreement, purchase price per share (in dollars per share) Equity Securities, Stock Purchase Agreement, Shares Purchased Equity Securities, Stock Purchase Agreement, Shares Purchased Equity securities, stock purchase agreement, shares purchased (in shares) Equity Securities, Stock Purchase Agreement, Par Value Per Share Equity Securities, Stock Purchase Agreement, Par Value Per Share Equity securities, stock purchase agreement, par value per share (in dollars per share) License And Option Agreement, Milestone Payments License And Option Agreement, Milestone Payments Milestone payment Collaborative Arrangement, Written Notice Period For Termination Collaborative Arrangement, Written Notice Period For Termination Written notice for agreement termination Biogen M.A., Inc. Biogen M.A., Inc. [Member] Biogen M.A., Inc. Collaboration And License Agreements Collaboration And License Agreements [Text Block] Collaboration and License Agreements Temporary Equity, Options, Share-Based Payment Arrangement, Increase For Cost Recognition Temporary Equity, Options, Share-Based Payment Arrangement, Increase For Cost Recognition Stock-based compensation expense Adjustments to Additional Paid in Capital, Distribution Of Contingent Value Rights Adjustments to Additional Paid in Capital, Distribution Of Contingent Value Rights Distribution of contingent value rights Stock Issued During Period, Shares, Common Warrants Exercised Stock Issued During Period, Shares, Common Warrants Exercised Issuance of common stock upon exercise of common warrants (in shares) Private Placement Two Private Placement Two [Member] Private Placement Two Private Placement One Private Placement One [Member] Private Placement One Temporary Equity, Stock Issued During Period, Acquisitions, Value Temporary Equity, Stock Issued During Period, Acquisitions, Value Issuance of Series A Preferred Stock in connection with the Merger and settlement of related forward contract Temporary Equity, Stock Issued During Period, Acquisitions, Shares Temporary Equity, Stock Issued During Period, Acquisitions, Shares Issuance of Series A Preferred Stock in connection with the Merger and settlement of related forward contract (in shares) Adjustments to Additional Paid in Capital, Issuance Of Common Stock Forward In Connection With The Merger Adjustments to Additional Paid in Capital, Issuance Of Common Stock Forward In Connection With The Merger Issuance of common stock forward in connection with the Merger Temporary Equity, Options, Issuance Of Replacement Options In Merger Temporary Equity, Options, Issuance Of Replacement Options In Merger Issuance of replacement options in Merger Stock Issued During the Period, Values, Common Stock and Warrants Stock Issued During the Period, Values, Common Stock and Warrants Issuance of common stock and common warrants Increase (Decrease) In Temporary Equity, Option, Roll Forward Increase (Decrease) In Temporary Equity, Option, Roll Forward [Roll Forward] Increase (Decrease) In Temporary Equity, Option, Roll Forward [Roll Forward] Adjustments to Additional Paid in Capital, Issuance Of Replacement Options In Merger Adjustments to Additional Paid in Capital, Issuance Of Replacement Options In Merger Issuance of replacement options in Merger Stock Issued During Period, Value, Common Warrants Exercised Stock Issued During Period, Value, Common Warrants Exercised Issuance of common stock upon exercise of warrants Stock Issued During the Period, Values, Common Stock License Agreement Stock Issued During the Period, Values, Common Stock License Agreement Issuance of common stock, license agreement Stock Issued During the Period, Shares, Common Stock License Agreement Stock Issued During the Period, Shares, Common Stock License Agreement Issuance of common stock, license agreement (in shares) Stock Issued During the Period, Shares, Common Stock and Warrants Stock Issued During the Period, Shares, Common Stock and Warrants Issuance of common stock and common warrants (in shares) Adjustments to Additional Paid in Capital, Settlement Of Outstanding Equity Awards Adjustments to Additional Paid in Capital, Settlement Of Outstanding Equity Awards Settlement of outstanding equity awards at Merger Adjustments to additional paid in capital, settlement of outstanding equity awards at merger Temporary Equity, Stock Issued During Period, Shares Temporary Equity, Stock Issued During Period, Shares Issuance of Series A Preferred Stock forward in connection with private placement and settlement of related forward contract (in shares) November 2023 Private Placement, Tranche One November 2023 Private Placement, Tranche One [Member] November 2023 Private Placement, Tranche One November 2023 Private Placement, Tranche Three November 2023 Private Placement, Tranche Three [Member] November 2023 Private Placement, Tranche Three November 2023 Private Placement, Tranche Two November 2023 Private Placement, Tranche Two [Member] November 2023 Private Placement, Tranche Two Preferred Stock, Convertible, Transaction Restrictions, Percentage Of Originally Issued Stock Issued And Outstanding Preferred Stock, Convertible, Transaction Restrictions, Percentage Of Originally Issued Stock Issued And Outstanding Preferred stock, convertible, transaction restrictions, percentage of originally issued stock issued and outstanding Securities Purchase Agreement Securities Purchase Agreement [Member] Securities Purchase Agreement Preferred Stock, Convertible, Threshold Consecutive Trading Days Preferred Stock, Convertible, Threshold Consecutive Trading Days Preferred stock, convertible, threshold consecutive trading days Preferred Stock, Convertible, Beneficial Ownership Percentage Preferred Stock, Convertible, Beneficial Ownership Percentage Beneficially holders owned percentage Settlement Of Derivative Liability, Shares Settlement Of Derivative Liability, Shares Derivative liability, shares (in shares) Obligation to issue stock (in shares) Sale Of Stock, Settlement Term Sale Of Stock, Settlement Term Sale of stock, settlement term Preferred Stock, Redemption Term Preferred Stock, Redemption Term Preferred stock, redemption term November 2023 Private Placement November 2023 Private Placement [Member] November 2023 Private Placement Temporary Equity, Shares Reserved For Future Issuance Temporary Equity, Shares Reserved For Future Issuance Shares reserved for issuance (in shares) Series A Preferred Stock Options Series A Preferred Stock Options [Member] Series A Preferred Stock options Forward Contract To Issue Shares Forward Contract To Issue Shares [Member] Forward contract to issue Series A Preferred Stock Noncash Or Part Noncash, Reclassification Of Warrant Liability To Equity Noncash Or Part Noncash, Reclassification Of Warrant Liability To Equity Reclassification of warrant liability to equity Noncash Or Part Noncash, Warrant Exercises Noncash Or Part Noncash, Warrant Exercises Cashless warrant exercise Increase (Decrease) In Contract with Customer, Asset, Allowance for Credit Loss, Current Increase (Decrease) In Contract with Customer, Asset, Allowance for Credit Loss, Current Unbilled receivable Unbilled receivable Proceeds From Issuance Of Common Stock And Warrants Proceeds From Issuance Of Common Stock And Warrants Net proceeds from issuance of common stock and common warrants At-The-Market Offering [Member] At-The-Market Offering [Member] At-The-Market Offering Payment For Settlement Of Equity Awards In Business Combination Payment For Settlement Of Equity Awards In Business Combination Settlement of outstanding equity awards at Merger Descartes-08 for MG Descartes-08 for MG [Member] Descartes-08 for MG Descartes-08 for SLE Descartes-08 for SLE [Member] Descartes-08 for SLE Warrants And Rights Outstanding, Noncurrent Warrants And Rights Outstanding, Noncurrent Warrant liabilities, net of current portion Contingent Value Right Liability, Noncurrent Contingent Value Right Liability, Noncurrent Contingent value right liability, net of current portion Contingent Value Right Liability, Current Contingent Value Right Liability, Current Contingent value right liability Temporary Equity, Options, Carrying Amount, Attributable To Parent Temporary Equity, Options, Carrying Amount, Attributable To Parent Options for Series A Preferred Stock Ending balance Beginning balance Warrants And Rights Outstanding, Current Warrants And Rights Outstanding, Current Warrant liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right Of Use Asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right Of Use Asset Right-of-use asset, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Lease Liability Lease liability, net of current portion Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses And Other Current Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses And Other Current Liabilities Accrued expenses and other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Lease Liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Lease Liability Lease liability Old Cartesian Old Cartesian [Member] Old Cartesian Fair Value Adjustment Of Contingent Value Right Liability Fair Value Adjustment Of Contingent Value Right Liability Change in fair value of contingent value right liability Contingent value right liability revaluation Upfront Rental Payment Upfront Rental Payment Upfront rental payment Number Of Acquired Operating Leases Number Of Acquired Operating Leases Number of acquired operating leases Operating Lease, Base Rent Operating Lease, Base Rent Base rent 704 Quince Orchard Road Leases 704 Quince Orchard Road Leases [Member] 704 Quince Orchard Road Leases Moscow Russia Lease Moscow Russia Lease [Member] Moscow Russia Lease 65 Grove Street, Watertown, MA [Member] 65 Grove Street, Watertown, MA [Member] 65 Grove Street, Watertown,MA 65 Grove Street, Watertown, MA [Domain] for Lease Arrangement [Axis] Lease Arrangement [Domain] Lease Arrangement [Domain] Lease Arrangement [Axis] Lease Arrangement [Axis] Lease Arrangement [Axis] Cyrus Biotechnology, Inc. Cyrus Biotechnology, Inc. [Member] Cyrus Biotechnology, Inc. The entire disclosure for temporary equity. Temporary Equity Disclosure [Text Block] Series A Preferred Stock